Literature DB >> 28321555

Medical Treatment of Gastroesophageal Reflux Disease.

Daniel A Kroch1, Ryan D Madanick2.   

Abstract

Medical treatment is effective in the majority of patients with gastroesophageal reflux disease (GERD). Lifestyle modifications are often recommended for patients with GERD, although the data supporting lifestyle recommendations are limited. Antacids are often used to treat the symptoms of GERD, but their effect is short-lived. H2-receptor antagonists and proton-pump inhibitors provide more effective options for remission of GERD symptoms and healing of esophagitis. Prokinetic medications (e.g., metoclopramide) have not been proven to help in the control of symptoms. Baclofen, which inhibits transient lower esophageal sphincter relaxations, provide an additional option for patients with persistent symptoms related to GERD; however its use is limited by side effects. Long-term medical therapy for GERD should be tailored to each patient to provide symptomatic control and maintain esophageal mucosal healing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28321555     DOI: 10.1007/s00268-017-3954-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  61 in total

1.  Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.

Authors:  J G Hatlebakk; P O Katz; L Camacho-Lobato; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

Review 2.  Prokinetic therapy in gastroesophageal reflux disease.

Authors:  M C Champion
Journal:  Can J Gastroenterol       Date:  1997-09       Impact factor: 3.522

3.  Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.

Authors:  N T Gunaratnam; T P Jessup; J Inadomi; D P Lascewski
Journal:  Aliment Pharmacol Ther       Date:  2006-05-15       Impact factor: 8.171

Review 4.  Review article: metoclopramide and tardive dyskinesia.

Authors:  A S Rao; M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2010-01       Impact factor: 8.171

5.  Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis.

Authors:  R Weberg; A Berstad
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

Review 6.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 7.  Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease.

Authors:  G E Boeckxstaens; A Smout
Journal:  Aliment Pharmacol Ther       Date:  2010-05-18       Impact factor: 8.171

Review 8.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

9.  Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension.

Authors:  L M Mathus-Vliegen; G N Tytgat
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 2.566

10.  Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.

Authors:  G N Tytgat; G Simoneau
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

View more
  1 in total

Review 1.  Role of Non-pharmacological Interventions and Weight Loss in the Management of Gastroesophageal Reflux Disease in Obese Individuals: A Systematic Review.

Authors:  Maria Mukhtar; Mohammed J Alzubaidee; Raga Sruthi Dwarampudi; Sheena Mathew; Sumahitha Bichenapally; Vahe Khachatryan; Asmaa Muazzam; Chandani Hamal; Lakshmi Sai Deepak Reddy Velugoti; Godfrey Tabowei; Greeshma N Gaddipati; Safeera Khan
Journal:  Cureus       Date:  2022-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.